Literature DB >> 20363874

AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation.

Junyu Ning1, David R Clemmons.   

Abstract

AMP-activated protein kinase (AMPK) inhibits IGF-I actions, but the mechanism by which AMPK functions is undefined. This study identified signaling events that were induced by AMPK that mediated inhibition of IGF-I-stimulated phosphoinosotide-3-kinase (PI3K) pathway activation. The AMPK activator metformin stimulated AMPK Thr172 phosphorylation and inhibited IGF-I-stimulated phosphorylation of Akt/tuberous sclerosis 2 (TSC2)/mammalian target of rapamycin (mTOR)/p70S6 kinase (p70S6K). Expression of constitutively active forms of AMPK suppressed IGF-I-stimulated activation of Akt/TSC2/mTOR/p70S6K and protein synthesis, whereas AMPK knockdown resulted in enhanced responses to IGF-I. To determine the mechanism by which AMPK inhibited IGF-I signaling, the role of insulin receptor substrate-1 (IRS-1) was examined. Both metformin and constitutively activated AMPK enhanced phosphorylation of IRS-1 Ser794, which led to decreased IRS-1 tyrosine phosphorylation and recruitment of the p85 subunit of PI3K. Overexpression of IRS-1 S794A was associated with increased IGF-I-stimulated IRS-1 tyrosine phosphorylation, p85 association, and protein synthesis. To determine whether other signaling molecules mediated the effect of AMPK, TSC2 function was examined. Cells overexpressing TSC2/S1345A (the site of AMPK phosphorylation) were less responsive to metformin-induced inhibition of p70S6 kinase. These findings are relevant to whole animal physiology because administration of metformin to mice resulted in inhibition of IGF-I-stimulated phosphorylation of Akt/mTOR/p70S6K. In conclusion, AMPK functions to inhibit IGF-I-stimulated PI3K pathway activation through stimulation of IRS-1 serine 794 phosphorylation. Because IGF-I is an important stimulant of the anabolic response, this effect of AMPK could account for part of its inhibitory effect on protein synthesis, thus allowing more efficient energy use by other cellular processes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20363874      PMCID: PMC2875806          DOI: 10.1210/me.2009-0474

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  41 in total

Review 1.  The AMP-activated protein kinase--fuel gauge of the mammalian cell?

Authors:  D G Hardie; D Carling
Journal:  Eur J Biochem       Date:  1997-06-01

2.  Smooth muscle-targeted overexpression of insulin-like growth factor I results in enhanced vascular contractility.

Authors:  G Zhao; R L Sutliff; C S Weber; J Wang; J Lorenz; R J Paul; J A Fagin
Journal:  Endocrinology       Date:  2001-02       Impact factor: 4.736

3.  Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly.

Authors:  A Colao; S Spiezia; G Cerbone; R Pivonello; P Marzullo; D Ferone; C Di Somma; A P Assanti; G Lombardi
Journal:  Clin Endocrinol (Oxf)       Date:  2001-04       Impact factor: 3.478

4.  5'-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside.

Authors:  S N Jakobsen; D G Hardie; N Morrice; H E Tornqvist
Journal:  J Biol Chem       Date:  2001-10-11       Impact factor: 5.157

5.  Effects of stimulation of AMP-activated protein kinase on insulin-like growth factor 1- and epidermal growth factor-dependent extracellular signal-regulated kinase pathway.

Authors:  J Kim; M Y Yoon; S L Choi; I Kang; S S Kim; Y S Kim; Y K Choi; J Ha
Journal:  J Biol Chem       Date:  2001-03-21       Impact factor: 5.157

Review 6.  The insulin-like growth factor axis: A review of atherosclerosis and restenosis.

Authors:  A Bayes-Genis; C A Conover; R S Schwartz
Journal:  Circ Res       Date:  2000-02-04       Impact factor: 17.367

7.  Dexamethasone inhibits insulin-like growth factor signaling and potentiates myoblast apoptosis.

Authors:  J R Singleton; B L Baker; A Thorburn
Journal:  Endocrinology       Date:  2000-08       Impact factor: 4.736

8.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.

Authors:  Ken Inoki; Yong Li; Tianquan Zhu; Jun Wu; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

9.  Akt regulates growth by directly phosphorylating Tsc2.

Authors:  Christopher J Potter; Laura G Pedraza; Tian Xu
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

10.  Treatment with TNF-alpha and IFN-gamma alters the activation of SER/THR protein kinases and the metabolic response to IGF-I in mouse c2c12 myogenic cells.

Authors:  Katarzyna Grzelkowska-Kowalczyk; Wioletta Wieteska-Skrzeczyńska
Journal:  Cell Mol Biol Lett       Date:  2009-08-14       Impact factor: 5.787

View more
  40 in total

Review 1.  Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes.

Authors:  David R Clemmons
Journal:  Endocrinol Metab Clin North Am       Date:  2012-06       Impact factor: 4.741

2.  Lewis lung carcinoma regulation of mechanical stretch-induced protein synthesis in cultured myotubes.

Authors:  Song Gao; James A Carson
Journal:  Am J Physiol Cell Physiol       Date:  2015-10-21       Impact factor: 4.249

3.  Berberine improves mesenteric artery insulin sensitivity through up-regulating insulin receptor-mediated signalling in diabetic rats.

Authors:  Feng-Hao Geng; Guo-Hua Li; Xing Zhang; Peng Zhang; Ming-Qing Dong; Zhi-Jing Zhao; Yuan Zhang; Ling Dong; Feng Gao
Journal:  Br J Pharmacol       Date:  2016-04-05       Impact factor: 8.739

4.  Suppression of AMPK activation via S485 phosphorylation by IGF-I during hyperglycemia is mediated by AKT activation in vascular smooth muscle cells.

Authors:  Junyu Ning; Gang Xi; David R Clemmons
Journal:  Endocrinology       Date:  2011-06-14       Impact factor: 4.736

5.  Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle.

Authors:  I Chopra; H F Li; H Wang; K A Webster
Journal:  Diabetologia       Date:  2011-12-30       Impact factor: 10.122

6.  Metformin: direct inhibition of rat ovarian theca-interstitial cell proliferation.

Authors:  Matthew A Will; Murugesan Palaniappan; Helle Peegel; Pradeep Kayampilly; K M J Menon
Journal:  Fertil Steril       Date:  2012-05-17       Impact factor: 7.329

Review 7.  Metformin--mode of action and clinical implications for diabetes and cancer.

Authors:  Ida Pernicova; Márta Korbonits
Journal:  Nat Rev Endocrinol       Date:  2014-01-07       Impact factor: 43.330

8.  AMPK-induced activation of Akt by AICAR is mediated by IGF-1R dependent and independent mechanisms in acute lymphoblastic leukemia.

Authors:  Gilles M Leclerc; Guy J Leclerc; Guilian Fu; Julio C Barredo
Journal:  J Mol Signal       Date:  2010-09-23

9.  Metformin exaggerates phenylephrine-induced AMPK phosphorylation independent of CaMKKβ and attenuates contractile response in endothelium-denuded rat aorta.

Authors:  Rajkumar Pyla; Islam Osman; Prahalathan Pichavaram; Paul Hansen; Lakshman Segar
Journal:  Biochem Pharmacol       Date:  2014-08-29       Impact factor: 5.858

Review 10.  Dietary antiaging phytochemicals and mechanisms associated with prolonged survival.

Authors:  Hongwei Si; Dongmin Liu
Journal:  J Nutr Biochem       Date:  2014-03-12       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.